PhRMA Asks Supreme Court to Reverse 3rd Circuit’s ‘Rogue’ Anti-Pay-for-Delay Decision

PhRMA is asking the Supreme Court to take up and overturn the 3rd Circuit Court’s decision that reverse patent settlements between generics and branded drug makers violate antitrust law. The trade organization submitted an amicus brief this week in support of Merck and Upsher-Smith’s petitions for a Supreme Court ruling after the 3rd Circuit created a split among the U.S. appeals courts on the issue.
Drug Industry Daily